CASI Pharmaceuticals
CASI
#9477
Rank
$44.21 M
Marketcap
$2.86
Share price
-5.30%
Change (1 day)
-57.69%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -$29.75 Million USD

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are $22.05 Million USD. In 2023 the company made an earning of -$26.38 Million USD, an increase over its 2022 earnings that were of -$37.44 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$29.75 Million12.79%
2023 -$26.38 Million-29.55%
2022 -$37.44 Million4.43%
2021 -$35.85 Million-24.56%
2020 -$47.52 Million4.74%
2019 -$45.37 Million65.13%
2018 -$27.48 Million155.07%
2017 -$10.78 Million13.93%
2016 -$9.46 Million31.18%
2015 -$7.21 Million-72.5%
2014 -$26.21 Million356.62%
2013 -$5.74 Million-60.55%
2012 -$14.55 Million218.41%
2011 -$4.57 Million0.74%
2010 -$4.54 Million-32.54%
2009 -$6.73 Million-66.98%
2008 -$20.36 Million-14.22%
2007 -$23.74 Million7.04%
2006 -$22.18 Million27.95%
2005 -$17.33 Million4.51%
2004 -$16.58 Million-15.84%
2003 -$19.7 Million-55.29%
2002 -$44.07 Million-34.05%
2001 -$66.82 Million31.73%
2000 -$50.72 Million31.56%
1999 -$38.56 Million145.56%
1998 -$15.7 Million76.4%
1997 -$8.9 Million36.92%
1996 -$6.5 Million